| Detected | Trial | Change |
|---|---|---|
| 2026-05-29 | NCT06979453 A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165)… |
Trial sites expanded: 120 -> 123 locations |
| 2026-05-28 | NCT07116967 Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With… |
Trial sites expanded: 357 -> 363 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT06875960 | A Study to Continue the Administration of Deucravacitinib in Participants With Systemic… | Systemic Lupus Erythematosus (SLE) | Recruiting |
| NCT05858645 | Correction of Psoriatic T Cell Signatures by Deucravacitinib | Psoriasis Vulgaris | Recruiting |
| NCT07280702 | Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease | Psoriatic Arthritis (PsA) | Not Yet Recruiting |
| NCT07352566 | Utilization of a Microdevice for Psoriasis and Atopic Dermatitis | Psoriasis | Not Yet Recruiting |
| Phase 3 | |||
| NCT07116967 | Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With… | Plaque Psoriasis | Recruiting |
| NCT06979453 | A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165)… | Plaque Psoriasis | Recruiting |
| NCT04772079 | A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children… | Plaque Psoriasis | Recruiting |
| NCT06869551 | A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165)… | Juvenile Psoriatic Arthritis | Recruiting |
| NCT06143878 | A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque… | Plaque Psoriasis | Active, Not Recruiting |
| NCT06220604 | A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque… | Plaque Psoriasis | Active, Not Recruiting |
| NCT05946941 | A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active… | Sjögren's Syndrome | Active, Not Recruiting |
| NCT04908202 | A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in… | Psoriatic Arthritis | Active, Not Recruiting |
| Phase 2 | |||
| NCT06444399 | Deucravacitinib (BMS-986165) for Pityriasis Rubra Pilaris | Pityriasis Rubra Pilaris | Recruiting |
| NCT07335796 | A Study of BMS986365 in Combination With Degarelix in People With Prostate Cancer | Prostate Cancer | Recruiting |
| NCT07508488 | Deucravacitinib in the Treatment of Cicatricial Alopecias | Central Centrifugal Cicatricial Alopecia | Recruiting |
| NCT06327321 | Vitiligo Treatment by Targeting TYK2 Mediated Responses | Vitiligo, Generalized | Active, Not Recruiting |
| Not specified | |||
| NCT07564271 | Clinical Characteristics and Mechanism Research of Deucravacitinib in the Idiopathic… | Idiopathic Inflammatory Myopathies (IIMs) | Recruiting |
| NCT06701513 | A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque… | Psoriasis | Recruiting |
| NCT06512337 | A Observational Study to Evaluate Deucravacitinib in Patients With Moderate Plaque… | Plaque Psoriasis | Active, Not Recruiting |
| NCT06999941 | A Real-world Study of Deucravacitinib in the Treatment of Moderate to Severe Plaque… | Psoriasis | Enrolling by Invitation |